Early Initiation of High-flow Nasal Cannula Oxygen Therapy in Patients With Acute Respiratory Failure in the Emergency Department: A Before-after Study
- Conditions
- Acute Respiratory Failure
- Registration Number
- NCT03447457
- Lead Sponsor
- Poitiers University Hospital
- Brief Summary
- The aim of the study is to compare the efficiency on respiratory failure regression of high-flow nasal oxygen therapy versus standard oxygen in patients admitted to the ED for de novo acute respiratory failure. 
- Detailed Description
- Prospective observational before-after study at the ED in two French centers. 
 Selection of patients with acute hypoxemic respiratory failure at the ED.
 Application of oxygen strategy according to the period:
 * before period: standard oxygen delivered through nasal cannula, face mask or non-rebreathing reservoir mask, with a flow rate adjusted to maintain a pulse oxymetry of at least 92%.
 * after period: high-flow oxygen therapy continuously applied via large-bore nasal prongs with a gas flow rate of 50 L/min and a FiO2 adjusted to maintain a pulse oxymetry at least 92%.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 102
- de novo acute respiratory failure cowith the following criteria: a respiratory rate > 25 b/min, or signs of increased work of breathing.
Main exclusion Criteria:
- cardiogenic pulmonary edema,
- acute exacerbation of chronic lung disease, respiratory acidosis (pH < 7.35 and PaCO2 > 50 mm Hg),
- hemodynamic instability
- Glasgow Coma Scale score of 12 points or less,
- an urgent need for endotracheal intubation,
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Primary Outcome Measures
- Name - Time - Method - complete regression of respiratory failure - one hour after initiation of oxygen strategies - respiratory rate less than 25 breaths per minute and regression of signs of increased work of breathing 
- Secondary Outcome Measures
- Name - Time - Method 
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (2)
- CHG de Niort 🇫🇷- Niort, France - CHU Poitiers 🇫🇷- Poitiers, France CHG de Niort🇫🇷Niort, France
